Tag: Shigella
Bharat Biotech to advance development of GSK’s Shigella vaccine candidate for...
The company in-licenses altSonflex1-2-3, a promising Shigella vaccine candidate, from GSK for continued clinical development and scale-up
EVI & Hilleman Labs announce partnership to assess a new vaccine...
Funding from European and Developing Countries Clinical Trials Partnership (EDCTP) will allow testing of a novel whole-cell inactivated oral vaccine in clinical trials in Europe and Africa.................
Hilleman Lab partners with NICED, ICMR to develop Shigella vaccine
The Hilleman Laboratories on March 29, 2017 signed a memorandum of understanding (MoU) with NICED, ICMR to develop an indigenous Shigella vaccine.....